These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Results of the treatment of cardiovascular symptoms with Cardiopon]. Hartmann K. Z Allgemeinmed; 1969 Jul 20; 45(20):966-9. PubMed ID: 4982010 [No Abstract] [Full Text] [Related]
4. [Clinical trial of proscillaridin A]. Jenny S, Forster G, Schultheiss M. Schweiz Med Wochenschr; 1971 Jul 03; 101(26):972-5. PubMed ID: 5169066 [No Abstract] [Full Text] [Related]
5. [Proscillaridin A in the therapy of decompensated heart diseases]. Vigna L, Mollica G. Minerva Cardioangiol; 1968 Oct 10; 16(10):987-90. PubMed ID: 5750066 [No Abstract] [Full Text] [Related]
6. [Clinical observations on the use of a combination of proscillaridin and theophylline in the treatment of the senile heart and chronic cor pulmonale]. Martinetti L, Lai G, Rovera R. Clin Ter; 1968 Sep 30; 46(6):517-42. PubMed ID: 5754593 [No Abstract] [Full Text] [Related]
7. [Drug therapy of circulatory disorders in old age]. Schönwald H. Med Monatsschr; 1968 Mar 30; 22(3):130-2. PubMed ID: 5753419 [No Abstract] [Full Text] [Related]
8. [Changes of the electrocardiograms of heart disease patients caused by the administration of proscillaridin A]. Martelli A. Cuore Circ; 1966 Oct 30; 50(5):283-307. PubMed ID: 6011723 [No Abstract] [Full Text] [Related]
9. [Clinical experience in the use of proscillaridin A in cardiac patients with tubercular bronchopneumopathy]. Concina E, Spataro C, Migliaccio A, Piacenza G. Minerva Med; 1971 Apr 28; 62(34):1769-82. PubMed ID: 5103638 [No Abstract] [Full Text] [Related]
10. [On the combined use of adonis vernalis with cardiac glycosides and strophanthin derivatives in treating patients with circulatory insufficiency]. Gubergrits AIa, Leshchinskiĭ LA. Sov Med; 1968 Jan 28; 31(1):23-7. PubMed ID: 5691025 [No Abstract] [Full Text] [Related]
11. [Study of the activity of a cardioactive glucoside, proscillaridin A, in ambulatory patients]. Parenti B, Cavasonza G. Minerva Cardioangiol; 1971 Jul 28; 19(7):376-83. PubMed ID: 5106123 [No Abstract] [Full Text] [Related]
12. [Experiences with the clinical use of proscillaridin A]. Milde HW. Med Welt; 1969 Mar 08; 10():531-5. PubMed ID: 5814419 [No Abstract] [Full Text] [Related]
13. [Comparative inquiry into ambulatory drug therapy of cardiovascular diseases in various median case-cost analysis]. Kneehans S, Sziegoleit W, Förster W. Dtsch Gesundheitsw; 1972 Nov 09; 27(45):2116-9. PubMed ID: 4650678 [No Abstract] [Full Text] [Related]
14. [Comparative hemodynamic effect of proscillaridin A and strophanthin]. Greggia G, Colombi M, Ranzi C, Ricci A. Cardiol Prat; 1967 Nov 09; 1(1):Suppl:1-7. PubMed ID: 5634200 [No Abstract] [Full Text] [Related]
15. [Our clinical experiences with the preparation Regasinum Cardiale]. Grujić M, Robović Z, Perinović M, Dragojević M, Ljubojević S. Med Arh; 1969 Nov 09; 23(1):71-6. PubMed ID: 5195982 [No Abstract] [Full Text] [Related]
17. [Clinical experiences with the "little heart therapy" acting on the myocardium and coronary vessels]. Baumgart R. Landarzt; 1966 Jan 20; 42(2):79-81. PubMed ID: 5949535 [No Abstract] [Full Text] [Related]
19. [Clinical experiences with Cardiopon, a cardiovascular system stimulating agent]. Voelker K. Med Welt; 1968 Jun 08; 23():1431-4. PubMed ID: 5752728 [No Abstract] [Full Text] [Related]